| » |
Hepato-cellular cancer (HCC) is the fifth most common cancer worldwide and, it is the third most common cause of cancer mortality |
| » |
At Transgene, we developed a novel and effective drug using unique miRNA based vector system to knock-down or silence the specific gene, causing the disease. |
| » |
The drug has demonstrated remarkable tumor regression in in-vitro and animal xenograft efficacy studies. |
| |
|
 |
|
|
(TBL) Subcutaneous tumor growth in SCID mice. The drug has been injected subcutaneously in 6 week old SCID mice. Tumor growth is measured twice weekly. The above depicted measurement of tumor was after 8 weeks. |
|
| » |
TBL is preparing to advance to pre-clinical studies. |
| » |
The management plans to out-license this drug soon after completion of pre-clinical studies. |
